This year, the EULAR 2022 Congress will be hosted both virtually and in-person in Copenhagen, providing the first-ever hybrid congress experience. DelveInsight is attending the conference in-person extensively to cover the various tracks and sessions. It will be an excellent opportunity for the DelveInisght team to learn from the various medical practitioners, scientists, individuals with arthritis/rheumatism, health workers, and pharmaceutical company representatives from all over the world working in the Rheumatology domain.
At EULAR 2022, DelveIsight’s team will be analyzing the abstracts and valuable findings acrossRheumatology segment. Primary researchers will be interacting with various KOLs to get a comprehensive view of their perceptions of novel therapies in development in the Rheumatology domain. As DelveInsight will be gaining valuable insights from the conference, which it will craft in its upcoming market research reports from the Rheumatology field. Furthermore, analysts from DelveInsight will be providing valuable insights into companies' strategy, clinical development of rheumatology pipeline candidates, and analysis of regulatory timelines.
Let’s Connect with our subject matter experts for a one-to-one meeting at the EULAR 2022 or if your company wants to track EULAR 2022.
Join DelveInsight from June 01-04, 2022, simply by filling up the form towards the right.
DelveInsight will present and cover various abstracts from the Rheumatology segment that will be releasing during the conference. DelveInsight will also collect all the insights from various representatives across the world, which will further help them modify and create the forthcoming Rheumatology research reports according to the latest findings. The team can help you to gain insights about your competitor's product and valuable insights from KOLs.
DelveInsight offers various market, epidemiology, and pipeline reports covering the rheumatological segment for the indications like but not limited to Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Polymyalgia Rheumatica, Axial Spondyloarthritis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Systemic Juvenile Idiopathic Arthritis, and many more. Through our research assessment, we keep our clients up to date with the latest trends and developments in the space. We also provide customized and tailored report analysis as per the client's requirements.
DelveInsight provides the most recent market analysis, forecast, and industry trends happening in the Rheumatological market. Our holistic, strategic, and realistic market analysis helps the client to stay updated with the latest happenings in the rheumatological market in order to accelerate their business growth and overcome challenges. Our keen insights of the market forecast assessment help the client to understand the overall view of the market and how it will change in the coming years. The report includes market forecasts upto 2032 along with emerging therapy analysis. We also provide customized market assessment as per the requirements of the client.
DelveInsight offers a broad spectrum of pipeline analysis of Rheumatological reports such as Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Polymyalgia Rheumatica, Axial Spondyloarthritis, Ankylosing Spondylitis, and many more covering the trials from preclinical to marketed along with the competitive assessment. We also provide the products’ therapeutics assessment by development stage, product type, route of administration, molecule type, and MOA type. We also offer customized pipeline assessment for coverage across many geographies as per the need of the client.
DelveInsight offers an in-depth assessment of the historical and forecasted epidemiological trends of the Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Polymyalgia Rheumatica, Axial Spondyloarthritis, Ankylosing Spondylitis reports covering the Rheumatological domain. The epidemiological assessment provides a comprehensive picture of all rheumatological diseases, including its causes, classification, pathophysiology, diagnosis, and treatment patterns. Our epidemiology assessment will assist you in tracking the growth opportunities for all rheumatological diseases across various geographies. We also offer customized epidemiology analysis for coverage across many geographies specified to the client's area of interest.
We have a specialized primary Competitive Intelligence research team that has expertise in the field of rheumatology. Our Competitive Intelligence team, comprised of analysts, senior analysts, managers, and key opinion leaders, provides our partners with the most up-to-date and accurate intelligence available in the rheumatological domain. Our competitive intelligence consulting services provide research-based solutions to help you gain a competitive advantage in the rheumatology market. Our strategy takes into account the perspectives of customers, suppliers, business competitors, and others. We gather market data from all corners of the rheumatological industry and transform it into useful knowledge.
DelveInsight welcomes everyone who wants to discuss their business-related concerns so that we can together find the best possible solution to help you outlast your competitors and grow in the Rheumatology competitive domain
Rajesh is an extremely enthusiastic and dedicated professional who is self motivated, hard working and having decision making ability. With more than 10+ years of experience in market research having expertise in Market intelligence, BD&L, Strategic Planning and Forecasting. Throughout these years his major focus was Oncology and Rare Diseases space.
The EULAR 2022 European Congress of Rheumatology is happening in:
Bella Center Copenhagen, Center Boulevard 5, DK - 2300 Copenhagen
